- pHERV-W（1）
- SARS-CoV-2（1）
No data
- His Tag（1）
- His Tag & GST Tag（1）
No data
- E. coli（1）
- HEK293（1）
No data
- Unconjugated（2）
No data
- RUO（2）
No data
- No（2）
No data
- 100ug/$360.00
- 1mg (200ug X 5)/$2615.00
No data
- 100ug/$336.00
- 1mg/$2184.00
No data
| Molecule | Cat. No. | Product Name | Species | Host | Structure | Purity | Activity | Size&Price | Add to Cart |
|---|---|---|---|---|---|---|---|---|---|
| Envelope protein | SARS-CoV-2 (COVID-19) Envelope protein, GST,His Tag | SARS-CoV-2 | E. coli |  | SDS-PAGE | $360.00 100ug |   | ||
| Envelope protein | pHERV-W Envelope protein, His Tag | pHERV-W | HEK293 |  | SDS-PAGE | $336.00 100ug | |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Targeting HIV-1 Env gp140 antibodies | Phase 2 Clinical | National Institute Of Allergy And Infectious Diseases (Niaid) | HIV Infections | Details | |
| Temelimab | GNN-001; GENHP-01; GNbAC-1 | Phase 2 Clinical | Geneuro Sa | Diabetes Mellitus, Type 1; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Post-Acute COVID-19 Syndrome | Details |
| VIS-513 | VIS-513; Ab-513 | Phase 2 Clinical | Otsuka Pharmaceutical Co Ltd, Serum Institute Of India Ltd, Visterra Inc | Dengue | Details |
| PGDM-1400 | PGDM-1400; PGDM1400LS | Phase 2 Clinical | International Aids Vaccine Initiative | Acquired Immunodeficiency Syndrome; HIV Infections; Sexually Transmitted Diseases, Viral | Details |
| MGD-020 | MGD020 | Phase 1 Clinical | Macrogenics Inc | HIV Infections | Details |
| GS-8588 | GS-8588 | Phase 1 Clinical | Gilead Sciences Inc | HIV Infections | Details |
| English Name | Research Code | Highest Development Stage | Company | Earliest Brand Name | Earliest Approval Country | Earliest Indication | Earliest Approval Company | Earliest Approval Date | Indication | Clinical Trial |
|---|---|---|---|---|---|---|---|---|---|---|
| Tecovirimat | SIGA-246; ST-246 | Approved | Siga Technologies Inc | Tpoxx, Arestvyr | United States | Smallpox | Siga Technologies Inc | 2018-07-13 | Cowpox; Monkeypox; Orthopoxvirus Infection; Poxviridae Infections; Smallpox; Vaccinia | Details |
